The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Genetic and Immunologic Heterogeneity among Persons Who Control HIV Infection in the Absence of Therapy
Abstract
BACKGROUND: Spontaneous control of human immunodeficiency virus (HIV) infection has been documented in a minority of HIV-infected individuals. The mechanisms behind this outcome remain largely unknown, and a better understanding of them will likely influence future vaccine strategies. METHODS: HIV-specific T cell and antibody responses as well as host genetics were examined in untreated HIV-infected patients who maintain comparatively low plasma HIV RNA levels (hereafter, controllers), including those with levels of < 50 RNA copies/mL (elite controllers, n = 64), those with levels of 50-2000 copies/mL (viremic controllers, n = 60); we also examined HIV-specific T cell and antibody responses as well as host genetics for patients with levels of >10,000 copies/mL (chronic progressors, n = 30). RESULTS: CD8+ T cells from both controller groups preferentially target Gag over other proteins in the context of diverse HLA class I alleles, whereas responses are more broadly distributed in persons with progressive infection. Elite controllers represent a distinct group of individuals who have significantly more CD4 and CD8 T cells that secrete interferon-gamma and interleukin-2 and lower levels of HIV-neutralizing antibodies. Individual responses were quite heterogeneous, and none of the parameters evaluated was uniquely associated with the ability to control viremia. CONCLUSIONS: Elite controllers are a distinct group, even when compared to persons with low level viremia, but they exhibit marked genetic and immunologic heterogeneity. Even low-level viremia among HIV controllers was associated with measurable T cell dysfunction, which has implications for current prophylactic vaccine strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
Dragic, T., Litwin, V., Allaway, G. P., Martin, S. R., Huang, Y., Nagashima, K. A., Cayanan, C., Maddon, P. J., Koup, R. A., Moore, J. P., et al. (1996) · Nature · doi:10.1038/381667a0 · Cited by 3,174
Viral Load and Heterosexual Transmission of Human Immunodeficiency Virus Type 1
Quinn, T. C., Wawer, M. J., Sewankambo, N., Serwadda, D., Li, C., Wabwire-Mangen, F., Meehan, M. O., Lutalo, T., & Gray, R. H. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003303421303 · Cited by 3,020
Vigorous HIV-1-Specific CD4 + T Cell Responses Associated with Control of Viremia
Rosenberg, E. S., Billingsley, J. M., Caliendo, A. M., Boswell, S. L., Sax, P. E., Kalams, S. A., & Walker, B. D. (1997) · Science · doi:10.1126/science.278.5342.1447 · Cited by 1,835
Self-citationHIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells
Betts, M. R. (2006) · Blood · doi:10.1182/blood-2005-12-4818 · Cited by 1,826
Gray, R. H., Wawer, M. J., Brookmeyer, R., Sewankambo, N. K., Serwadda, D., Wabwire-Mangen, F., Lutalo, T., Li, X., vanCott, T., & Quinn, T. C. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04331-2 · Cited by 1,281
HLA and HIV-1: Heterozygote Advantage and B*35-Cw*04 Disadvantage
Carrington, M., Nelson, G. W., Martin, M. P., Kissner, T., Vlahov, D., Goedert, J. J., Kaslow, R., Buchbinder, S., Hoots, K., & O'Brien, S. J. (1999) · Science · doi:10.1126/science.283.5408.1748 · Cited by 1,224
Rapid evolution of the neutralizing antibody response to HIV type 1 infection
Richman, D. D., Wrin, T., Little, S. J., & Petropoulos, C. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0630530100 · Cited by 1,200
Self-citationCao, Y., Qin, L., Zhang, L., Safrit, J., & Ho, D. D. (1995) · New England Journal of Medicine · doi:10.1056/nejm199501263320401 · Cited by 1,037
Migueles, S. A., Laborico, A. C., Shupert, W. L., Sabbaghian, M. S., Rabin, R., Hallahan, C. W., Baarle, D. V., Kostense, S., Miedema, F., McLaughlin, M., et al. (2002) · Nature Immunology · doi:10.1038/ni845 · Cited by 1,005
Migueles, S. A., Sabbaghian, M. S., Shupert, W. L., Bettinotti, M. P., Marincola, F. M., Martino, L., Hallahan, C. W., Selig, S. M., Schwartz, D., Sullivan, J., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050567397 · Cited by 995
Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA
Kiepiela, P., Leslie, A. J., Honeyborne, I., Ramduth, D., Thobakgale, C., Chetty, S., Rathnavalu, P., Moore, C., Pfafferott, K. J., Hilton, L., et al. (2004) · Nature · doi:10.1038/nature03113 · Cited by 842
Self-citationStudies in Subjects with Long-Term Nonprogressive Human Immunodeficiency Virus Infection
Pantaleo, G., Menzo, S., Vaccarezza, M., Graziosi, C., Cohen, O. J., Demarest, J. F., Montefiori, D., Orenstein, J. M., Fox, C., Schrager, L. K., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199501263320402 · Cited by 730
CCR5 Levels and Expression Pattern Correlate with Infectability by Macrophage-tropic HIV-1, In Vitro
Wu, L., Paxton, W. A., Kassam, N., Ruffing, N., Rottman, J. B., Sullivan, N., Choe, H., Sodroski, J., Newman, W., Koup, R. A., et al. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.9.1681 · Cited by 694
Betts, M. R., Ambrozak, D. R., Douek, D. C., Bonhoeffer, S., Brenchley, J. M., Casazza, J. P., Koup, R. A., & Picker, L. J. (2001) · Journal of Virology · doi:10.1128/jvi.75.24.11983-11991.2001 · Cited by 689
Addo, M. M., Yu, X. G., Rathod, A., Cohen, D., Eldridge, R. L., Strick, D., Johnston, M. N., Corcoran, C., Wurcel, A. G., Fitzpatrick, C. A., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.3.2081-2092.2003 · Cited by 669
Self-citationSáez-Cirión, A., Lacabaratz, C., Lambotte, O., Versmisse, P., Urrutia, A., Boufassa, F., Barré-Sinoussi, F., Delfraissy, J.-F., Sinet, M., Pancino, G., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611244104 · Cited by 616
Mother-to-Child Transmission of HIV Infection in the Era of Highly Active Antiretroviral Therapy
Study, E. C. (2005) · Clinical Infectious Diseases · doi:10.1086/427287 · Cited by 553
Younes, S.-A., Yassine-Diab, B., Dumont, A. R., Boulassel, M.-R., Grossman, Z., Routy, J.-P., & Sékaly, R.-P. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20031598 · Cited by 460
Martinez-Picado, J., Prado, J. G., Fry, E. E., Pfafferott, K., Leslie, A., Chetty, S., Thobakgale, C., Honeyborne, I., Crawford, H., Matthews, P., et al. (2006) · Journal of Virology · doi:10.1128/jvi.80.7.3617-3623.2006 · Cited by 446
Self-citationLambotte, O., Boufassa, F., Madec, Y., Nguyen, A., Goujard, C., Meyer, L., Rouzioux, C., Venet, A., Delfraissy, J.-F., & SEROCO-HEMOCO Study Group (2005) · Clinical Infectious Diseases · doi:10.1086/433188 · Cited by 409
Harari, A., Petitpierre, S., Vallelian, F., & Pantaleo, G. (2004) · Blood · doi:10.1182/blood-2003-04-1203 · Cited by 378
Lichterfeld, M., Kaufmann, D. E., Yu, X. G., Mui, S. K., Addo, M. M., Johnston, M. N., Cohen, D., Robbins, G. K., Pae, E., Alter, G., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041270 · Cited by 339
Self-citationHARRER, T., HARRER, E., KALAMS, S. A., ELBEIK, T., STAPRANS, S. I., FEINBERG, M. B., CAO, Y., HO, D. D., YILMA, T., CALIENDO, A. M., et al. (1996) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1996.12.585 · Cited by 327
Self-citationPilgrim, A. K., Pantaleo, G., Cohen, O. J., Fink, L. M., Zhou, J. Y., Zhou, J. T., Bolognesi, D. P., Fauci, A. S., & Montefiori, D. C. (1997) · The Journal of Infectious Diseases · doi:10.1086/516508 · Cited by 326
Zimmerli, S. C., Harari, A., Cellerai, C., Vallelian, F., Bart, P.-A., & Pantaleo, G. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502393102 · Cited by 307
Bailey, J. R., Williams, T. M., Siliciano, R. F., & Blankson, J. N. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052319 · Cited by 283
Frahm, N., Korber, B. T., Adams, C. M., Szinger, J. J., Draenert, R., Addo, M. M., Feeney, M. E., Yusim, K., Sango, K., Brown, N. V., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.5.2187-2200.2004 · Cited by 274
Self-citationSacha, J. B., Chung, C., Rakasz, E. G., Spencer, S. P., Jonas, A. K., Bean, A. T., Lee, W., Burwitz, B. J., Stephany, J. J., Loffredo, J. T., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.2746 · Cited by 267
An HIV Vaccine — Evolving Concepts
Johnston, M. I., & Fauci, A. S. (2007) · New England Journal of Medicine · doi:10.1056/nejmra066267 · Cited by 257 · cited 1×
“to induce a controller phenotype [15].”
Giorgi, J. V., Lyles, R. H., Matud, J. L., Yamashita, T. E., Mellors, J. W., Hultin, L. E., Jamieson, B. D., Margolick, J. B., Rinaldo, C. R., Phair, J. P., et al. (2002) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200204010-00004 · Cited by 246
Frahm, N., Kiepiela, P., Adams, S., Linde, C. H., Hewitt, H. S., Sango, K., Feeney, M. E., Addo, M. M., Lichterfeld, M., Lahaie, M. P., et al. (2006) · Nature Immunology · doi:10.1038/ni1281 · Cited by 226
Self-citationEmu, B., Sinclair, E., Favre, D., Moretto, W. J., Hsue, P., Hoh, R., Martin, J. N., Nixon, D. F., McCune, J. M., & Deeks, S. G. (2005) · Journal of Virology · doi:10.1128/jvi.79.22.14169-14178.2005 · Cited by 215
Bailey, J. R., Lassen, K. G., Yang, H.-C., Quinn, T. C., Ray, S. C., Blankson, J. N., & Siliciano, R. F. (2006) · Journal of Virology · doi:10.1128/jvi.80.10.4758-4770.2006 · Cited by 172
Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates
Haynes, B. F., & Montefiori, D. C. (2006) · Expert Review of Vaccines · doi:10.1586/14760584.5.3.347 · Cited by 155
Honeyborne, I., Prendergast, A. J., Pereyra, F., Leslie, A. J., Crawford, H., Payne, R., Reddy, S., Bishop, K. S., Moodley, E. S., Nair, K., et al. (2007) · Journal of Virology · doi:10.1128/jvi.02689-06 · Cited by 146
Self-citationCCR2-64I allele and genotype association with delayed AIDS progression in African women
Ao, A., Ball, T. B., Rostron, T., Os'Brien, S., Plummer, F., & Rowland-Jones, S. L. (1998) · The Lancet · doi:10.1016/s0140-6736(05)77688-1 · Cited by 99
Lambert, M., Gannagé, M., Karras, A., Abel, M., Legendre, C. M., Kérob, D., Agbalika, F., Girard, P., Lebbé, C., & Caillat‐Zucman, S. (2006) · Blood · doi:10.1182/blood-2006-03-014225 · Cited by 79
Feeney, M. E., Roosevelt, K. A., Tang, Y., Pfafferott, K. J., McIntosh, K., Burchett, S. K., Mao, C., Walker, B. D., & Goulder, P. (2003) · Journal of Virology · doi:10.1128/jvi.77.13.7492-7501.2003 · Cited by 33
Self-citation
Cited by
Buchbinder, S. P., Mehrotra, D. V., Duerr, A., Fitzgerald, D. W., Mogg, R., Li, D., Gilbert, P. B., Lama, J. R., Marmor, M., del Rio, C., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61591-3 · Cited by 1,713
Quigley, M., Pereyra, F., Nilsson, B., Porichis, F., Fonseca, C., Eichbaum, Q., Julg, B., Jesneck, J. L., Brosnahan, K., Imam, S., et al. (2010) · Nature Medicine · doi:10.1038/nm.2232 · Cited by 517
Self-citationHsue, P. Y., Hunt, P. W., Schnell, A., Kalapus, S. C., Hoh, R., Ganz, P., Martin, J. N., & Deeks, S. G. (2009) · AIDS · doi:10.1097/qad.0b013e32832b514b · Cited by 388
Lambotte, O., Ferrari, G., Moog, C., Yates, N. L., Liao, H.-X., Parks, R. J., Hicks, C. B., Owzar, K., Tomaras, G. D., Montefiori, D. C., et al. (2009) · AIDS · doi:10.1097/qad.0b013e328329f97d · Cited by 342
HIV and HLA Class I: An Evolving Relationship
Goulder, P. J. R., & Walker, B. D. (2012) · Immunity · doi:10.1016/j.immuni.2012.09.005 · Cited by 322
Self-citation
Metadata
- Authors
- Pereyra, F., Addo, M. M., Kaufmann, D. E., Liu, Y., Miura, T., Rathod, A., Baker, B., Trocha, A., Rosenberg, R., Mackey, E., Ueda, P., Lu, Z., Cohen, D., Wrin, T., Petropoulos, C. J., Rosenberg, E. S., & Walker, B. D.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-02-15
- Volume
- 197
- Issue
- 4
- Pages
- 563-571
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2138575726
- Cited by
- 540
- References
- 38
- FWCI
- 19.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.